{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:25:15Z","timestamp":1791181515136,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.beha.2011.02.007","type":"journal-article","created":{"date-parts":[[2011,5,22]],"date-time":"2011-05-22T16:46:16Z","timestamp":1306082776000},"page":"135-146","source":"Crossref","is-referenced-by-count":57,"title":["The microenvironment in follicular lymphoma"],"prefix":"10.1016","volume":"24","author":[{"given":"Daphne","family":"de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Fest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2011.02.007_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood.V99.1.282","article-title":"Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays","volume":"99","author":"Husson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2004-06-2298","article-title":"Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment","volume":"105","author":"Glas","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","article-title":"Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma","volume":"25","author":"Glas","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.007_bib4","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2011.02.007_bib5","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib6","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib7","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1080\/10428190701665954","article-title":"Biologic predictors in follicular lymphoma: importance of markers of immune response","volume":"48","author":"Kelley","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2011.02.007_bib8","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1200\/JCO.2006.10.5833","article-title":"Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group","volume":"25","author":"Klapper","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.007_bib9","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2006.06.4642","article-title":"Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.007_bib10","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1158\/1078-0432.CCR-07-0778","article-title":"A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone","volume":"13","author":"Taskinen","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2011.02.007_bib11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/1078-0432.CCR-06-1734","article-title":"CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma","volume":"13","author":"Wahlin","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2011.02.007_bib12","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1200\/JCO.2006.06.4766","article-title":"Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients","volume":"24","author":"Alvaro","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.007_bib13","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1182\/blood-2007-11-125823","article-title":"Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP","volume":"111","author":"Taskinen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3324\/haematol.13574","article-title":"Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols","volume":"94","author":"de Jong","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2011.02.007_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1200\/JCO.2007.12.8298","article-title":"High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial","volume":"26","author":"Canioni","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.007_bib16","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdp460","article-title":"Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study","volume":"21","author":"Sweetenham","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2011.02.007_bib17","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1182\/blood-2009-11-253260","article-title":"Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment","volume":"115","author":"Clear","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib18","doi-asserted-by":"crossref","unstructured":"de Jong D, Rosenwald A, Chhanabhai M, et al. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications\u2013a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol 2007;25:805\u2013812.","DOI":"10.1200\/JCO.2006.09.4490"},{"key":"10.1016\/j.beha.2011.02.007_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/jcp.2008.057257","article-title":"Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)","volume":"62","author":"de Jong","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.beha.2011.02.007_bib20","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1200\/JCO.2005.03.4744","article-title":"HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial","volume":"24","author":"Perez","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.007_bib21","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.2008.18.0513","article-title":"High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma","volume":"27","author":"Carreras","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.007_bib22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1158\/1078-0432.CCR-09-2487","article-title":"A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1\u2013positive, regulatory, cytotoxic, and helper T cells and macrophages","volume":"16","author":"Wahlin","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2011.02.007_bib23","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1182\/blood-2006-02-003921","article-title":"Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells","volume":"108","author":"Irish","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib24","doi-asserted-by":"crossref","first-page":"12747","DOI":"10.1073\/pnas.1002057107","article-title":"B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression","volume":"107","author":"Irish","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2011.02.007_bib25","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1182\/blood.V99.6.2192","article-title":"Tumor cell dissemination in follicular lymphoma","volume":"99","author":"Oeschger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib26","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/sj.leu.2400822","article-title":"In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand","volume":"11","author":"Buske","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2011.02.007_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V91.1.244","article-title":"Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival","volume":"91","author":"Ghia","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib28","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V82.6.1848.1848","article-title":"Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40\/stromal cell system","volume":"82","author":"Johnson","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1471-4906(01)01942-1","article-title":"Follicular dendritic cells: beyond the necessity of T-cell help","volume":"22","author":"Tew","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nri2644","article-title":"New insights into the differentiation and function of T follicular helper cells","volume":"9","author":"King","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0952-7915(97)80078-7","article-title":"Functions of CD40 on B cells, dendritic cells and other cells","volume":"9","author":"van Kooten","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib32","first-page":"912","article-title":"CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease","volume":"147","author":"Carbone","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2011.02.007_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/(SICI)1099-1069(199711)15:4<197::AID-HON614>3.0.CO;2-V","article-title":"T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cells","volume":"15","author":"Schmitter","year":"1997","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.beha.2011.02.007_bib34","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4049\/jimmunol.181.2.1001","article-title":"CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL","volume":"181","author":"Travert","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib35","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.4049\/jimmunol.155.7.3329","article-title":"Opposing roles of CD95 (Fas\/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells","volume":"155","author":"Cleary","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ni.1877","article-title":"PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells","volume":"11","author":"Good-Jacobson","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20091738","article-title":"IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses","volume":"207","author":"Linterman","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2011.02.007_bib38","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/leu.2010.223","article-title":"Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis","volume":"24","author":"Pangault","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2011.02.007_bib39","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2008-02-138933","article-title":"IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma","volume":"112","author":"Calvo","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib40","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2004-10-3820","article-title":"Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas","volume":"105","author":"Lu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib41","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/leu.2009.103","article-title":"STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line","volume":"23","author":"Baus","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2011.02.007_bib42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ni.1715","article-title":"Cytokine-secreting follicular T cells shape the antibody repertoire","volume":"10","author":"Reinhardt","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib43","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.leu.2403323","article-title":"Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL","volume":"18","author":"Hardianti","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2011.02.007_bib44","doi-asserted-by":"crossref","unstructured":"Okada T, Miller MJ, Parker I, et al. 2005. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol 3:e150.","DOI":"10.1371\/journal.pbio.0030150"},{"key":"10.1016\/j.beha.2011.02.007_bib45","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.4049\/jimmunol.170.4.1887","article-title":"Human activation-induced cytidine deaminase is induced by IL-4 and negatively regulated by CD45: implication of CD45 as a Janus kinase phosphatase in antibody diversification","volume":"170","author":"Zhou","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/08830189309061709","article-title":"Processing and presentation of idiotypes to MHC-restricted T cells","volume":"10","author":"Bogen","year":"1993","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib47","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1084\/jem.20061220","article-title":"Lymphomas can develop from B cells chronically helped by idiotype-specific T cells","volume":"204","author":"Zangani","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2011.02.007_bib48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ijc.23881","article-title":"Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells","volume":"124","author":"Ai","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beha.2011.02.007_bib49","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1182\/blood-2009-04-217687","article-title":"Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy","volume":"114","author":"Ramsay","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib50","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1182\/blood-2005-08-3376","article-title":"Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma","volume":"107","author":"Yang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib51","doi-asserted-by":"crossref","first-page":"10145","DOI":"10.1158\/0008-5472.CAN-06-1822","article-title":"Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2011.02.007_bib52","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1158\/0008-5472.CAN-09-0266","article-title":"Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma","volume":"69","author":"Yang","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2011.02.007_bib53","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1182\/blood-2008-07-170274","article-title":"T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy","volume":"113","author":"Houot","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib54","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2010.28.9793","article-title":"In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A\u00a0Phase I\/II Study","author":"Brody","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2011.02.007_bib55","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2009-05-223263","article-title":"Generation of CD8+ T cell-mediated immunity against idiotype-negative lymphoma escapees","volume":"114","author":"Varghese","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib56","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4049\/jimmunol.0901980","article-title":"gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes","volume":"184","author":"Braza","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-2776(05)87005-1","article-title":"The biology of human lymphoid malignancies revealed by gene expression profiling","volume":"87","author":"Staudt","year":"2005","journal-title":"Adv Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib58","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nri2588","article-title":"Stromal cell contributions to the homeostasis and functionality of the immune system","volume":"9","author":"Mueller","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib59","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood-2006-05-020800","article-title":"Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis","volume":"109","author":"Ame-Thomas","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib60","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-08-3000","article-title":"Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase","volume":"69","author":"Maby-El Hajjami","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2011.02.007_bib61","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib62","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccr.2004.08.031","article-title":"Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis","volume":"6","author":"Yang","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2011.02.007_bib63","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.beha.2011.02.007_bib64","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL","volume":"3","author":"Litinskiy","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib65","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1189\/jlb.0706481","article-title":"Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation","volume":"82","author":"Mueller","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.beha.2011.02.007_bib66","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1182\/blood-2008-07-166892","article-title":"Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction","volume":"112","author":"Rafei","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib67","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1084\/jem.20061292","article-title":"Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis","volume":"03","author":"Roulland","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.beha.2011.02.007_bib68","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib69","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nri2779","article-title":"Phagocyte partnership during the onset and resolution of inflammation","volume":"10","author":"Soehnlein","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.beha.2011.02.007_bib70","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.beha.2011.02.007_bib71","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood-2005-02-0642","article-title":"Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine","volume":"106","author":"Beyer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib72","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","article-title":"Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients","volume":"56","author":"Ghiringhelli","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.beha.2011.02.007_bib73","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood-2004-06-2410","article-title":"Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide","volume":"105","author":"Lutsiak","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2011.02.007_bib74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2141.2009.07773.x","article-title":"Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma","volume":"146","author":"Friedberg","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2011.02.007_bib75","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nrd3031","article-title":"Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells","volume":"8","author":"Wang","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.beha.2011.02.007_bib76","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692611000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692611000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T23:32:21Z","timestamp":1686094341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692611000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1521692611000144"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2011.02.007","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}